TeamFrank Behrens, M.D.: Medical Director and Managing Partner of CIRI
Raised in Lower Franconia, Dr. Behrens initially studied biology at the Johannes Gutenberg University in Mainz and continued with medicine. He obtained his M.D. at the Johann Wolfgang Goethe University in Frankfurt am Main, where he received training in internal medicine and rheumatology. He moved to Frankfurt’s Pharmaceutical Center in 2003 to work on a grant-supported research project on regulatory T-cells (immunopharmacology), and returned to rheumatology thereafter.
He has been working in clinical research and drug development since 2001 He built up the functional area of clinical rheumatology research at the Goethe University Medical Center, which he has managed since 2007.
Subsequent to the founding ofthe interdisciplinary “Center for Drug Research, Development and Safety (ZAFES)“ as an institute of the Goethe University, he has been co-ordinating the rheumatology division. In 2011, Dr. Behrens founded the “Center for Innovative Diagnostics and Therapy in Rheumatology/Immunology (CIRI)” together with his co-partners, as a Goethe University partner institute to carry out clinical research and systematically advance the development of this field in Frankfurt am Main.
Dr. Behrens is a (founding) member of various international committees and study groups such as GRAPPA (Group of Research and Assessment of Psoriasis and Psoriatic Arthritis), EPOSS (Expert Panel on Outcome of Systemic Sclerosis), PAGE (Psoriatic Arthritis Genetic European Consortium) and others. Since 2001, he has accumulated experience in clinical study implementation as a principal investigator, chief investigator and managing investigator for Germany. He is co-responsible for one of the largest investigator-initiated studies (IIT) in rheumatology in Germany and initiator of NESTRA, the German Study Network.